Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026)

Bicycle Therapeutics posted quarterly Other Non-Current Assets of $13.0 million for Q1 2026, up 5.11% year-on-year from $12.4 million in Q1 2025, and up 1.46% on a QoQ basis from $12.8 million in Q4 2025.

Bicycle Therapeutics (BCYC) has 9 years of Other Non-Current Assets data on file, last reported at $13.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 5.11% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $13.0 million (up 5.11% YoY), and the FY2025 full-year result was $12.8 million, up 15.63% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $13.0 million, up from $12.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $13.8 million in Q2 2025 and bottomed at $4.2 million in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $9.9 million (2024), against an average of $9.3 million.
  • The widest annual swing landed in 2023, when Other Non-Current Assets jumped 151.69%; it then tumbled 45.83% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $8.5 million in 2022, then slumped by 31.52% to $5.8 million in 2023, then surged by 91.19% to $11.1 million in 2024, then rose by 15.63% to $12.8 million in 2025, then rose by 1.46% to $13.0 million in 2026.
  • The last three Other Non-Current Assets figures came in at $13.0 million (Q1 2026), $12.8 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 60,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 63.55 Mn
10 Bicycle Therapeutics 326.82 Mn 326.82 Mn - 12.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 12.99 Mn
Dec 31, 2025 12.81 Mn
Sep 30, 2025 13.71 Mn
Jun 30, 2025 13.81 Mn
Mar 31, 2025 12.36 Mn
Dec 31, 2024 11.07 Mn
Sep 30, 2024 9.94 Mn
Jun 30, 2024 6.58 Mn
Mar 31, 2024 6.37 Mn
Dec 31, 2023 5.79 Mn
Sep 30, 2023 5.45 Mn
Jun 30, 2023 12.15 Mn
Mar 31, 2023 10.57 Mn
Dec 31, 2022 8.46 Mn
Sep 30, 2022 6.16 Mn
Jun 30, 2022 5.10 Mn
Mar 31, 2022 4.20 Mn
Dec 31, 2021 3.45 Mn
Sep 30, 2021 2.78 Mn
Jun 30, 2021 2.38 Mn
Mar 31, 2021 2.18 Mn
Dec 31, 2020 1.82 Mn
Sep 30, 2020 2.40 Mn
Jun 30, 2020 2.27 Mn
Mar 31, 2020 1.87 Mn
Dec 31, 2019 1.70 Mn
Sep 30, 2019 1.48 Mn
Jun 30, 2019 1.41 Mn
Dec 31, 2018 3.04 Mn